≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified coagulation defects

DOID EFO Endpoint Browser PheWeb

D3_COAGDEFNAS

blood coagulation disease: A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D68.8, D68.9
  • Hospital discharge: ICD-9 — 2869
  • Hospital discharge: ICD-8 — 2869
  • Cause of death: ICD-10 — D68.8, D68.9
  • Cause of death: ICD-9 — 2869
  • Cause of death: ICD-8 — 2869

2 out of 7 registries used, show all original rules.

1856

4. Check minimum number of events

None

1856

5. Include endpoints

None

1856

6. Filter based on genotype QC (FinnGen only)

1856

Control definitions (FinnGen only)

Control exclude
D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11374 7399 3902
Only index persons 10454 6997 3457
Unadjusted period prevalence (%)
Whole population 0.18 0.21 0.11
Only index persons 0.22 0.26 0.13
Median age at first event (years)
Whole population 41.80 37.06 50.90
Only index persons 41.92 37.10 51.69

-FinnGen-

Key figures

All Female Male
Number of individuals 1856 1290 566
Unadjusted period prevalence (%) 0.38 0.44 0.25
Median age at first event (years) 45.73 40.98 56.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1627
Matched controls
16269
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D68.9
ICD-10 Finland
Coagulation defect, unspecified
1062.7
323.0
402
5
D68.8
ICD-10 Finland
Other specified coagulation defects
5305.6
323.0
1312
12
B01AA03
ATC
warfarin; systemic
11.1
323.0
756
1177
B01AB05
ATC
enoxaparin; parenteral
9.2
323.0
1064
2778
B01AB04
ATC
dalteparin; parenteral
15.1
183.6
320
260
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
14.1
142.5
254
211
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
10.2
126.4
265
304
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
436.1
123.5
122
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.8
119.4
382
819
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
13.7
112.4
201
165
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
22.2
110.0
163
81
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
38.2
97.1
124
35
Z2221
NOMESCO Finland
Medical doctor
3.2
95.4
710
3185
XF400
NOMESCO Finland
ECG with 12 standard connections
4.1
88.9
408
1235
D68.0
ICD-10 Finland
Von Willebrand disease
883.5
86.4
84
*
R4110
NOMESCO Finland
Physiotherapy
3.0
77.0
579
2526
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
74.5
769
4066
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
16.0
71.7
119
80
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
23.1
71.5
104
48
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.4
64.0
362
1264
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
63.3
703
3768
ZXE00
NOMESCO Finland
One hour or less
2.4
62.2
803
4644
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.6
61.0
166
276
Z3226
NOMESCO Finland
Physiotherapist
3.0
59.7
418
1689
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
59.1
746
4231
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
56.9
213
514
Z3231
NOMESCO Finland
Registered nurse
2.6
56.8
563
2792
R06.0
ICD-10 Finland
Dyspnoea
2.7
54.5
473
2163
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
54.2
312
1090
K94
ICPC
Phlebitis/thrombophlebitis
13.2
53.7
96
77
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
12.5
52.4
96
81
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
186.0
52.2
54
*
B01AB10
ATC
tinzaparin; parenteral
4.6
52.0
196
474
M79.6
ICD-10 Finland
Pain in limb
2.3
50.7
669
3788
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
50.0
422
1884
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
3.2
47.9
280
982
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
6.5
47.3
129
214
N02AX02
ATC
tramadol; systemic, rectal
2.1
44.1
718
4392
126
Kela drug reimbursment
Chronic coagulation defects
+∞
42.9
41
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
42.7
519
2772
ZXD05
NOMESCO Finland
Urgent procedure
2.2
42.3
611
3527
WX892
NOMESCO Finland
Monitored bed care
3.9
39.1
173
483
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.8
38.7
175
498
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
38.5
496
2695
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
38.5
508
2790
N02BE01
ATC
paracetamol; systemic, rectal
2.4
36.8
1400
11741
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
36.7
262
1038
K99
ICPC
Cardiovascular disease other
7.2
35.9
89
129
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
9.0
35.3
76
88
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
9.1
34.5
74
85
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.3
34.5
134
331
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
10.2
34.5
69
70
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
34.0
195
665
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
33.4
402
2094
H02AB07
ATC
prednisone; oral
2.5
31.9
275
1211
R4120
NOMESCO Finland
Occupational therapy
3.7
31.8
150
440
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
89.4
31.8
35
*
ZX120
NOMESCO Finland
Intravenous
3.0
31.8
199
720
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
31.8
776
5322
Z2446
NOMESCO Finland
Social worker
3.4
31.5
164
521
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
13.6
31.1
54
41
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
31.0
190
678
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
30.9
286
1303
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
12.9
30.9
55
44
C03CA01
ATC
furosemide; systemic
2.2
30.4
361
1860
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
30.3
237
986
WX002
NOMESCO Finland
Sedation and analgesia
2.2
30.2
340
1710
K78
ICPC
Atrial fibrillation/flutter
3.7
29.7
135
384
B01AX05
ATC
fondaparinux; parenteral
19.2
29.7
45
24
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
29.0
409
2265
I87.0
ICD-10 Finland
Postthrombotic syndrome
34.4
28.8
37
11
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.8
28.6
126
349
H02AB06
ATC
prednisolone; systemic
1.8
28.5
742
5137
J01DB01
ATC
cefalexin; oral
2.0
28.4
1344
11378
I26
ICD-10 Finland
Pulmonary embolism
17.0
27.2
43
26
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.7
27.1
197
783
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
26.8
641
4286
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
26.5
215
908
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.4
26.0
132
410
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
25.7
416
2415
AA1AD
NOMESCO Finland
CT of head and brain
2.1
25.7
352
1912
R60.0
ICD-10 Finland
Localized oedema
2.7
25.7
195
793
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.6
25.4
120
352
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
25.1
148
512
C07AB07
ATC
bisoprolol; oral
1.8
24.9
622
4188
ZXA00
NOMESCO Finland
Right side
1.9
24.5
405
2365
A02BC02
ATC
pantoprazole; systemic
1.7
24.3
991
7726
ZXA05
NOMESCO Finland
Left side
2.0
24.3
377
2145
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
38.2
24.0
30
8
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
23.1
23.9
34
15
Z71.8
ICD-10 Finland
Other specified counselling
1.9
23.8
438
2655
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
23.7
114
340
L04AX01
ATC
azathioprine; systemic
3.8
23.3
101
276
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
23.3
611
4157
XF404
NOMESCO Finland
Ambulatory ECG
2.7
23.2
164
639
J01MA12
ATC
levofloxacin; systemic
2.1
22.9
280
1442
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
121.7
22.6
24
*
L17
ICPC
Foot/toe symptom/complaint
1.9
22.4
411
2479
N03AX16
ATC
pregabalin; oral
1.9
22.2
373
2179
B01AF01
ATC
rivaroxaban; oral
2.6
22.2
171
700
K93
ICPC
Pulmonary embolism
10.5
22.1
43
42
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
63.4
21.9
25
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
21.8
318
1756
J01MA02
ATC
ciprofloxacin; systemic
1.7
21.6
571
3868
R51.80
ICD-10 Finland
Headache
2.1
21.6
291
1561
A02BC01
ATC
omeprazole; systemic
1.8
21.3
428
2657
XA800
NOMESCO Finland
Neuropsychological investigation
3.6
21.1
99
290
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
20.7
188
840
315
Kela drug reimbursment
Clopidogrel
13.1
20.7
36
28
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
20.6
136
505
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
20.6
148
581
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
20.6
545
3684
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
20.6
424
2650
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
20.6
289
1572
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
20.4
190
857
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
48.6
20.2
24
5
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
19.9
180
802
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
19.7
152
619
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
9.3
19.4
40
44
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.3
19.4
196
921
3AC01
NOMESCO Finland
NA
7.6
19.2
45
61
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
19.1
256
1364
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
18.8
83
231
L04AA06
ATC
mycophenolic acid; systemic
5.7
18.8
54
97
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
18.8
234
1210
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
6.8
18.4
46
69
O22.3
ICD-10 Finland
Deep phlebothrombosis in pregnancy
16.4
18.3
29
18
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
18.2
118
432
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.3
18.2
68
163
R50.9
ICD-10 Finland
Fever, unspecified
2.1
18.2
229
1186
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
18.1
297
1707
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.1
18.0
104
356
A02BC05
ATC
esomeprazole; systemic
1.6
17.8
606
4352
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
17.5
114
419
XF402
NOMESCO Finland
ECG with work load test
2.4
17.5
151
657
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.4
17.4
64
151
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.9
17.4
110
399
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
17.0
511
3535
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.2
17.0
91
296
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
8.7
17.0
36
42
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.4
17.0
85
263
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.9
16.9
71
190
P01BA02
ATC
hydroxychloroquine; oral
2.4
16.9
152
674
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
16.9
239
1297
28698
ICD-8 Finland
Coagulation defects, Other
+∞
16.7
16
*
J01MA14
ATC
moxifloxacin; systemic
2.4
16.5
145
635
A46
ICD-10 Finland
Erysipelas
2.1
16.5
188
932
R04.0
ICD-10 Finland
Epistaxis
2.8
16.5
110
414
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
16.3
220
1171
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.7
16.2
46
82
XF620
NOMESCO Finland
Examination of circulation with color method
18.7
16.0
24
13
R03AC02
ATC
salbutamol; inhalant
1.5
15.9
828
6539
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
15.9
126
522
Z01.7
ICD-10 Finland
Laboratory examination
2.1
15.8
188
949
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
15.8
112
436
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
11.3
15.8
29
26
XW000
NOMESCO Finland
Bone marrow biopsy
3.7
15.7
68
187
L28
ICPC
Limited function/disability (L)
2.0
15.7
205
1075
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
15.6
15
*
B01AF02
ATC
apixaban; oral
2.5
15.5
127
537
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
15.2
333
2094
JN4BD
NOMESCO Finland
Extensive body CT
2.2
15.2
155
731
WX402
NOMESCO Finland
General anaesthesia
1.8
15.2
272
1605
I80
ICD-10 Finland
Phlebitis and thrombophlebitis
7.2
15.1
36
51
C10AA05
ATC
atorvastatin; oral
1.6
15.0
434
2954
45100
ICD-8 Finland
Phlebitis and thrombophlebitis, Of lower extremities
10.2
15.0
29
29
J01FF01
ATC
clindamycin; systemic
1.7
14.9
415
2793
M05BA04
ATC
alendronic acid; oral
2.6
14.7
107
424
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
21.2
14.7
21
10
E0000UV
ATC
NA
1.5
14.6
609
4535
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
14.6
267
1583
B83
ICPC
Purpura/coagulation defect
+∞
14.6
14
*
ZXA10
NOMESCO Finland
Bilateral
1.8
14.6
272
1624
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
12.0
14.6
26
22
WX110
NOMESCO Finland
Local anesthesy
1.5
14.5
1108
9455
J01FA06
ATC
roxithromycin; oral
1.5
14.4
610
4555
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
14.4
137
626
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
14.3
146
690
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
14.2
182
944
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.3
14.1
52
124
R42
ICD-10 Finland
Dizziness and giddiness
1.7
14.0
295
1830
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
13.9
119
514
K92.1
ICD-10 Finland
Melaena
3.0
13.8
80
275
D69.0
ICD-10 Finland
Allergic purpura
53.8
13.8
16
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
13.8
265
1597
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
13.7
121
529
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
+∞
13.6
13
*
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
+∞
13.6
13
*
D69.1
ICD-10 Finland
Qualitative platelet defects
+∞
13.6
13
*
R03BA02
ATC
budesonide; inhalant
1.8
13.5
280
1724
N02AA05
ATC
oxycodone; systemic
2.0
13.5
181
960
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
16.3
13.5
21
13
B99
ICPC
Blood/lymph/spleen disease other
16.3
13.5
21
13
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.9
13.4
83
298
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
13.3
108
455
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
13.3
125
568
R03DC03
ATC
montelukast; oral
1.8
13.3
267
1626
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
13.2
141
678
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
13.2
116
509
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.6
13.2
100
404
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.4
13.2
115
501
R02
ICPC
Shortness of breath/dyspnoea
2.0
13.2
173
909
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
13.1
272
1674
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
13.1
153
764
TK800
NOMESCO Finland
Hemodialysis
4.8
13.1
43
92
B02AA02
ATC
tranexamic acid; systemic
1.8
13.0
258
1566
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
12.9
127
589
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.6
12.9
98
396
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.7
12.8
43
94
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
5.0
12.8
40
81
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.8
12.8
54
147
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
12.7
171
909
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
8.3
12.5
27
33
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
12.5
171
911
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
12.3
738
5880
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.1
12.3
47
117
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.8
12.3
78
286
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
14.4
12.3
20
14
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
12.2
369
2518
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.0
12.2
71
246
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
7.5
12.2
28
38
Z2445
NOMESCO Finland
Psychologist
2.6
12.2
87
340
ZXD35
NOMESCO Finland
Usual procedure
3.1
12.1
66
219
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
12.1
111
499
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
12.1
532
3970
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
12.0
164
873
K22
ICPC
Risk factor cardiovascular disease
2.7
12.0
79
297
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.0
11.9
70
244
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
11.9
113
517
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
11.9
379
2620
A28
ICPC
Limited function/disability NOS
2.0
11.9
165
886
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
11.8
112
511
M25.5
ICD-10 Finland
Pain in joint
1.5
11.8
430
3070
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.7
11.8
78
294
N96
ICD-10 Finland
Habitual aborter
6.1
11.7
31
52
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.6
11.6
52
149
S16
ICPC
Bruise/contusion
3.3
11.5
58
182
J01MA06
ATC
norfloxacin; oral
1.8
11.5
204
1194
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
11.5
257
1613
L14
ICPC
Leg/thigh symptom/complaint
2.2
11.4
112
520
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.5
11.4
53
157
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
11.3
109
502
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.6
11.2
291
1907
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.3
11.2
106
484
A02BA02
ATC
ranitidine; systemic
1.7
11.2
259
1640
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.7
11.2
47
128
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.8
11.0
46
125
R06AE07
ATC
cetirizine; oral
1.4
10.9
681
5427
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.9
10.9
43
111
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.9
786
6441
Z31.5
ICD-10 Finland
Genetic counselling
2.2
10.9
106
491
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.5
10.9
37
83
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
10.9
293
1938
R06AX27
ATC
desloratadine; oral
1.5
10.9
441
3216
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.1
10.8
58
192
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
10.8
152
819
127
Kela drug reimbursment
Transplant complication
4.7
10.7
35
75
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
4.3
10.7
38
89
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
1.6
10.7
284
1872
I81
ICD-10 Finland
Portal vein thrombosis
13.0
10.6
18
14
WX722
NOMESCO Finland
PEEP
2.8
10.6
70
261
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
10.6
261
1681
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
10.6
81
332
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
10.5
272
1776
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
10.5
205
1234
A11CC03
ATC
alfacalcidol; systemic
3.9
10.5
42
110
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.1
10.5
119
587
J01DA01
ATC
[U] cefalexin; systemic
1.4
10.4
936
7956
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
110.7
10.4
11
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
10.4
206
1247
R03BB04
ATC
tiotropium bromide; inhalant
2.1
10.4
116
569
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
10.3
112
545
L04AD01
ATC
ciclosporin; systemic
3.9
10.3
41
107
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
10.3
72
279
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
10.3
457
3393
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
10.3
85
362
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.0
10.2
40
103
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
10.2
124
633
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.1
10.2
113
555
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
10.2
110
532
R31
ICD-10 Finland
Unspecified haematuria
2.1
10.2
115
569
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.2
10.1
30
58
O36.4
ICD-10 Finland
Maternal care for intrauterine death
6.9
10.1
24
35
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
10.1
601
4729
TAB00
NOMESCO Finland
Lumbar puncture
2.4
10.1
81
341
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
10.1
125
643
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.7
10.0
42
115
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
9.9
130
682
R5110
SPAT
NA
3.7
9.9
42
116
A11
ICPC
Chest pain NOS
2.3
9.9
94
431
C09AA05
ATC
ramipril; oral
1.6
9.8
257
1684
G47.3
ICD-10 Finland
Sleep apnoea
1.6
9.8
269
1787
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
9.8
227
1441
ZXD20
NOMESCO Finland
Day surgery
1.7
9.7
198
1211
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.3
9.7
47
145
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.5
9.7
43
124
J01AA02
ATC
doxycycline; systemic
1.4
9.7
1155
10273
R53
ICD-10 Finland
Malaise and fatigue
1.6
9.6
296
2019
A08
ICPC
Swelling
2.8
9.6
61
225
UJF32
NOMESCO Finland
Coloscopy
1.5
9.6
330
2313
PD5BD
NOMESCO Finland
Extensive CT of aorta
4.2
9.6
35
85
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.7
9.6
187
1128
R4190
NOMESCO Finland
Nutritional therapy
2.7
9.5
62
233
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
9.5
115
586
I50.0
ICD-10 Finland
Congestive heart failure
2.6
9.5
69
276
XPX08
NOMESCO Finland
Intraoperative flow measurement
9.1
9.5
19
21
H02AB04
ATC
methylprednisolone; systemic
1.7
9.5
204
1264
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.5
9.5
43
126
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
9.4
126
665
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
9.4
122
637
K84
ICPC
Heart disease other
3.8
9.4
38
101
Z86.7
ICD-10 Finland
Personal history of diseases of the circulatory system
100.6
9.4
10
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.3
9.4
85
379
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
17.6
9.4
14
8
R01AD05
ATC
budesonide; nasal
2.0
9.4
120
625
2869X
ICD-9 Finland
Coagulation defects, Other and unspecified coagulation defects
+∞
9.4
9
*
D68
ICD-10 Finland
Other coagulation defects
+∞
9.4
9
*
I82.80
ICD-10 Finland
Emboli and thrombosis in the subclavian vein
21.8
9.4
13
6
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
9.3
44
133
R52.9
ICD-10 Finland
Pain, unspecified
2.0
9.3
125
662
J01DA06
ATC
[U] cefuroxime; systemic
1.7
9.3
210
1322
K29
ICPC
Cardiovascular sympt/complt other
2.7
9.3
62
235
WW500
NOMESCO Finland
Blood transfusion
2.7
9.2
59
220
K90
ICPC
Stroke/cerebrovascular accident
3.6
9.2
40
114
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
9.1
78
340
A07AA02
ATC
nystatin; oral
2.3
9.1
83
372
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
9.1
78
341
B01AC04
ATC
clopidogrel; oral
1.8
9.1
157
910
C01CA24
ATC
epinephrine; parenteral
2.0
9.1
113
581
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
9.0
68
276
R01AD09
ATC
mometasone; nasal
1.4
9.0
682
5569
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.0
9.0
111
571
R4130
NOMESCO Finland
Speech therapy
3.5
9.0
40
116
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
8.9
256
1714
H02AB09
ATC
hydrocortisone; systemic
3.2
8.9
44
138
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
8.9
85
391
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.7
8.9
29
63
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.9
52
183
N30.0
ICD-10 Finland
Acute cystitis
1.7
8.9
206
1306
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
2.2
8.9
85
393
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
8.8
73
312
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.8
175
1059
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
8.8
138
773
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.9
8.8
52
185
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.1
8.7
102
512
XMA22
NOMESCO Finland
General examination of pregnant woman
1.9
8.7
117
622
Z71.9
ICD-10 Finland
Counselling, unspecified
2.1
8.7
91
437
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
8.7
155
909
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
8.6
130
720
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.1
8.6
26
52
GD1LA
NOMESCO Finland
GD
6.2
8.6
22
36
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.0
8.6
47
159
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.2
8.6
31
75
-60
ICPC
Result test/procedure
2.1
8.6
90
433
L05
ICPC
Flank/axilla symptom/complaint
2.3
8.6
80
365
R2110
NOMESCO Finland
Giving the first information
1.9
8.6
123
667
S97
ICPC
Chronic ulcer skin
2.5
8.6
65
266
J01CA04
ATC
amoxicillin; systemic
1.4
8.5
1268
11570
WW400
NOMESCO Finland
Plasmaferesis
27.7
8.5
11
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
20.1
8.5
12
6
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
8.5
305
2155
L04AA01
ATC
[U] ciclosporin; systemic
3.9
8.4
33
86
205
Kela drug reimbursment
Chronic hypertension
1.5
8.4
276
1908
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.1
8.4
45
150
R07.3
ICD-10 Finland
Other chest pain
1.9
8.4
128
711
I82.1
ICD-10 Finland
Thrombophlebitis migrans
90.5
8.4
9
*
R5599
NOMESCO Finland
Other rehabilitation service
3.1
8.4
44
145
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
8.3
287
2005
H53.4
ICD-10 Finland
Visual field defects
3.4
8.2
38
114
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.9
8.2
128
715
J01FA10
ATC
azithromycin; systemic
1.4
8.2
900
7765
M04AA01
ATC
allopurinol; systemic
1.9
8.2
126
704
A01
ICPC
Pain general/multiple sites
1.9
8.1
114
614
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
8.1
80
375
TFP20
NOMESCO Finland
Cardiodefibrillation
2.2
8.1
77
354
R05
ICD-10 Finland
Cough
1.5
8.1
260
1788
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
8.1
1227
13253
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
8.1
237
1596
N06AA09
ATC
amitriptyline; systemic
1.8
8.1
129
730
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
11.8
8.1
14
12
R04.2
ICD-10 Finland
Haemoptysis
3.0
8.1
46
158
N03AX12
ATC
gabapentin; oral
1.6
8.0
201
1300
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
5.1
8.0
24
48
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
8.0
141
823
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
8.0
49
179
A97
ICPC
No disease
1.6
8.0
208
1359
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.5
8.0
35
101
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.5
8.0
35
101
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
5.6
8.0
22
40
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.7
7.9
160
973
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
7.9
56
223
R4150
NOMESCO Finland
Neuropsychological rehabilitation
5.2
7.9
23
45
RS221
NOMESCO Finland
NA
3.8
7.9
31
82
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
7.8
27
63
ZZA00
NOMESCO Finland
Split skin graft
3.2
7.8
38
119
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
3.1
7.8
41
136
N05CF01
ATC
zopiclone; oral
1.4
7.8
402
3049
6BA02
NOMESCO Finland
NA
9.4
7.8
15
16
SPAT1229
SPAT
Assessment of need for aid
2.0
7.8
95
487
WZC30
NOMESCO Finland
Teaching
1.7
7.7
165
1019
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
7.7
170
1061
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.4
7.7
35
104
2BD01
NOMESCO Finland
NA
45.2
7.7
9
*
I74.2
ICD-10 Finland
Embolism and thrombosis of arteries of upper extremities
15.1
7.7
12
8
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
6.4
7.7
19
30
A41.9
ICD-10 Finland
Sepsis, unspecified
2.9
7.7
45
159
N18.8
ICD-10 Finland
Other chronic renal failure
3.5
7.7
34
99
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.1
7.7
28
69
ZY010
NOMESCO Finland
Hospital outpatient
2.1
7.7
84
413
L01XX05
ATC
hydroxycarbamide; oral
5.6
7.7
21
38
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
7.7
122
690
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
7.7
215
1431
R1260
NOMESCO Finland
Evaluation of communicative skills
4.0
7.7
29
74
C03DA01
ATC
spironolactone; oral
1.9
7.6
116
645
WX780
NOMESCO Finland
Remote monitoring CPAP
2.6
7.6
54
215
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
7.6
189
1218
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
18.4
7.6
11
6
280
Kela drug reimbursment
Clopidogrel
4.9
7.6
23
47
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.6
304
2194
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
7.6
66
293
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.6
582
4729
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
7.6
50
192
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.3
7.5
66
294
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
8.9
7.5
15
17
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
7.5
122
693
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.1
7.5
27
66
WW200
NOMESCO Finland
Immunization
2.7
7.5
48
180
R55
ICD-10 Finland
Syncope and collapse
1.8
7.5
129
749
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
1.8
7.5
122
697
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
7.4
172
1090
WX872
NOMESCO Finland
Intensive care
2.3
7.4
64
281
N02AC04
ATC
dextropropoxyphene; oral
2.8
7.4
45
164
D69.5
ICD-10 Finland
Secondary thrombocytopenia
80.4
7.4
8
*
C10AA01
ATC
simvastatin; oral
1.4
7.4
431
3335
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
7.7
7.4
16
21
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
2.7
7.4
48
182
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.6
7.4
20
36
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
7.4
94
490
M79.1
ICD-10 Finland
Myalgia
1.6
7.4
188
1223
J20
ICD-10 Finland
Acute bronchitis
1.7
7.3
140
838
J01FA09
ATC
clarithromycin; systemic
1.4
7.3
460
3608
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
7.3
153
939
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
7.3
134
792
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.5
7.2
20
37
L01
ICPC
Neck symptom/complaint
1.6
7.2
194
1277
N05BA01
ATC
diazepam; systemic, rectal
1.6
7.2
168
1065
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.4
7.2
57
241
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
7.1
196
1294
M32
ICD-10 Finland
Systemic lupus erythematosus
20.1
7.1
10
5
SBB10
NOMESCO Finland
Teeth copy
1.9
7.1
102
554
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
8.0
7.1
15
19
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.5
7.1
31
90
N03AX09
ATC
lamotrigine; oral
2.1
7.1
81
403
PH2AE
SPAT
NA
4.0
7.1
26
65
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.6
7.1
23
51
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
12.1
7.1
12
10
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
5.6
7.1
19
34
RD210
NOMESCO Finland
NA
2.9
7.0
41
145
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.2
7.0
67
310
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.7
7.0
46
176
C08CA01
ATC
amlodipine; oral
1.4
7.0
363
2747
M02AA07
ATC
piroxicam; topical
1.4
7.0
448
3520
JN4CD
NOMESCO Finland
Very extensive body CT
2.6
7.0
47
183
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.5
7.0
53
220
A07AA09
ATC
vancomycin; oral
4.9
7.0
21
43
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
7.0
624
5170
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.3
7.0
32
97
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.3
6.9
24
57
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
7.6
6.9
15
20
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
6.9
124
731
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
6.9
122
714
G44.2
ICD-10 Finland
Tension-type headache
1.6
6.9
199
1335
S20.2
ICD-10 Finland
Contusion of thorax
2.2
6.8
66
308
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.2
6.8
70
333
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.6
6.8
155
978
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
6.8
86
448
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.7
6.8
16
24
K60
ICPC
Cardiovascular, Result test/procedure
6.7
6.8
16
24
W84
ICPC
Pregnancy high risk
2.2
6.8
68
322
S18
ICPC
Laceration/cut
1.3
6.8
524
4238
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
6.8
105
586
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
9.3
6.8
13
14
WX882
NOMESCO Finland
High dependency care
2.8
6.8
41
150
RS220
NOMESCO Finland
NA
3.6
6.8
28
78
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.9
6.8
26
68
X58
ICD-10 Finland
Exposure to other specified factors
1.6
6.8
195
1304
45001
ICD-8 Finland
Pulmonary embolism and infarction, Embolia
40.2
6.8
8
*
PD4ST
NOMESCO Finland
Endovascular thrombolysis of pelvic and lower extremity arteries
40.2
6.8
8
*
D01
ICPC
Abdominal pain/cramps general
1.6
6.8
162
1037
3A064
NOMESCO Finland
NA
16.8
6.7
10
6
G43.9
ICD-10 Finland
Migraine, unspecified
1.8
6.7
105
591
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
6.7
133
807
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.6
6.7
157
999
B01AE07
ATC
dabigatran etexilate; oral
2.5
6.7
48
194
45309
ICD-8 Finland
Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)
22.6
6.7
9
*
S21
ICPC
Skin texture symptom/complaint
1.6
6.7
158
1009
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.2
6.6
23
55
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
5.5
6.6
18
33
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
6.6
205
1398
C09CA06
ATC
candesartan; oral
1.5
6.6
264
1899
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.6
6.6
151
955
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
6.6
46
181
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
6.5
94
515
O02.1
ICD-10 Finland
Missed abortion
1.8
6.5
101
565
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
6.5
38
135
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
6.5
195
1317
A60
ICPC
General and Unspecified, Result test/procedure
2.2
6.5
64
303
A99
ICPC
Disease/condition unspecnature/site
1.8
6.5
99
553
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
6.5
61
282
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
6.5
35
120
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
6.5
348
2648
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
6.4
203
1388
M54.5
ICD-10 Finland
Low back pain
1.4
6.4
463
3698
2BD06
NOMESCO Finland
NA
70.1
6.4
7
*
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
70.1
6.4
7
*
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
70.1
6.4
7
*
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
6.4
181
1205
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
6.4
45
177
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.0
6.4
34
115
R52.2
ICD-10 Finland
Other chronic pain
2.4
6.4
50
212
I27.0
ICD-10 Finland
Primary pulmonary hypertension
14.4
6.4
10
7
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.7
6.4
26
72
C08CA05
ATC
nifedipine; systemic
2.0
6.4
78
400
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.9
6.4
19
39
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
6.4
291
2151
318
Kela drug reimbursment
Teriparatide
6.6
6.3
15
23
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
6.6
6.3
15
23
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.8
6.3
38
139
R03AC12
ATC
salmeterol; inhalant
2.3
6.3
54
238
C08CA02
ATC
felodipine; oral
1.9
6.3
92
507
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.5
6.3
27
78
S22.3
ICD-10 Finland
Fracture of rib
2.0
6.3
78
405
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
9.3
6.3
12
13
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
4.6
6.3
20
44
XX9XW
NOMESCO Finland
NA
4.6
6.3
20
44
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
6.3
78
406
C10AA07
ATC
rosuvastatin; oral
1.5
6.3
248
1781
I87.8
ICD-10 Finland
Other specified disorders of veins
18.1
6.3
9
5
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
6.3
6
*
O991, D688
ICD-10 Finland
NA
+∞
6.3
6
*
PH7YT
NOMESCO Finland
Dilatation of inferior vena cava or lower extremity vein with stent
+∞
6.3
6
*
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
6.3
6
*
B02BD02
ATC
coagulation factor VIII; parenteral, topical, urethral
+∞
6.3
6
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
26.8
6.2
8
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.3
6.2
51
221
J01DC02
ATC
cefuroxime; systemic
1.9
6.2
93
516
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.5
6.2
183
1231
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
6.2
81
428
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.2
436
3469
D45
ICD-10 Finland
Polycythaemia vera
5.0
6.2
18
36
N06AX21
ATC
duloxetine; oral
1.6
6.2
145
921
TK810
NOMESCO Finland
Hemofiltration
6.3
6.2
15
24
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.5
6.1
45
185
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
6.1
151
973
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.6
6.1
41
160
WX110
SPAT
NA
2.0
6.1
70
352
1XC02
NOMESCO Finland
NA
7.7
6.1
13
17
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
7.7
6.1
13
17
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
6.1
380
2962
N03AF02
ATC
oxcarbazepine; oral
2.3
6.1
51
224
A02BC03
ATC
lansoprazole; oral
1.4
6.1
358
2763
K27
ICPC
Fear cardiovascular disease other
4.7
6.1
19
41
N05CF02
ATC
zolpidem; oral
1.5
6.1
239
1712
N06AX12
ATC
bupropion; oral
1.8
6.1
99
563
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
6.1
94
529
K55.8
ICD-10 Finland
Other vascular disorders of intestine
12.6
6.1
10
8
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.2
6.1
60
282
R06AX22
ATC
ebastine; oral
1.5
6.1
248
1789
WX320
NOMESCO Finland
Spinalanesthesy
1.4
6.1
286
2123
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
6.1
55
249
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
8.6
6.1
12
14
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
8.6
6.1
12
14
SBA10
NOMESCO Finland
Measurement of excretion of saliva
4.4
6.0
20
46
M01AH02
ATC
rofecoxib; oral
1.6
6.0
150
969
E66.8
ICD-10 Finland
Other obesity
1.9
6.0
86
471
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
10.1
6.0
11
11
B28
ICPC
Limited function/disability (B)
10.1
6.0
11
11
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
6.0
93
521

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
304
248
14.46
315.61
1.9
1.2
u/ml
10.6
3.9
4.51
155
99
(3036489) Thrombin time
543
556
13.39
307.65
4.6
2.2
s
21.8
21.0
1.10
465
476
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
522
429
16.54
307.65
5.8
2.6
%
162.7
175.2
1.81
499
408
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
450
419
13.86
307.65
5.5
2.9
g/l
3.4
3.6
2.01
431
396
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
527
475
15.10
307.65
4.7
2.5
%
97.5
91.7
4.87
489
438
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
326
250
15.61
307.65
1.9
1.2
u/ml
13.6
3.4
3.90
139
77
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
288
256
13.13
282.84
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
281
243
13.45
280.72
1.2
1.1
%
113.5
117.6
0.84
260
221
(4306422)
275
251
12.69
265.11
1.3
1.2
—
—
—
0
0
(4268621)
226
168
15.18
246.28
3.5
2.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
990
3595
4.76
244.00
7.5
3.7
%
84.8
93.6
13.31
965
3488
(3018677) aPTT in Platelet poor plasma by Coagulation assay
707
2023
5.03
234.99
6.1
2.1
s
33.5
29.6
18.91
692
1952
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
949
3450
4.58
230.74
4.0
1.7
mg/l
1.3
1.0
2.07
723
2585
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
215
179
13.45
218.70
1.2
1.1
%
87.2
94.8
2.05
201
169
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
284
371
8.86
209.45
6.7
3.2
u/ml
0.3
0.4
0.13
180
197
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
147
91
17.46
175.70
1.5
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1085
5196
3.62
160.85
24.6
7.5
inr
1.6
1.2
24.33
348
1623
(3022217) INR in Platelet poor plasma by Coagulation assay
498
1483
4.22
149.50
49.1
20.7
inr
1.8
1.2
5.50
36
222
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
71
11
67.07
129.36
1.7
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
585
2125
3.56
129.31
5.1
3.5
mmol/l
0.8
0.8
0.47
560
1985
(3034426) Prothrombin time (PT)
96
49
20.61
125.14
1.6
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
430
1350
3.84
117.33
4.5
4.2
u/l
235.2
249.0
0.81
419
1277
(3022096) Basophils/100 leukocytes in Blood
1193
6956
3.00
110.93
9.3
5.9
%
0.7
0.7
0.63
1141
6503
(42870588) Differential panel, method unspecified - Blood
958
4973
2.91
110.71
8.6
5.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
496
1795
3.41
108.02
4.1
2.4
%
23.4
23.4
0.00
465
1536
(3006504) Eosinophils/100 leukocytes in Blood
1210
7190
2.96
107.09
9.4
5.8
%
2.8
2.8
0.16
1159
6704
(3019069) Monocytes/100 leukocytes in Blood
1210
7239
2.93
104.81
9.6
6.1
%
8.5
8.3
2.13
1160
6808
(3004789) Transferrin [Mass/volume] in Serum or Plasma
515
1947
3.28
103.98
3.9
2.3
g/l
2.3
2.4
1.28
493
1814
(3006315) Basophils [#/volume] in Blood
1250
7696
2.91
100.91
9.1
5.8
e9/l
0.0
0.0
0.28
1076
6727
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
223
472
5.23
100.77
3.5
1.7
g/l
0.2
0.2
2.99
214
448
(3001604) Monocytes [#/volume] in Blood
1242
7666
2.87
98.94
9.1
5.7
e9/l
0.6
0.6
0.41
1072
6701
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
225
495
5.03
97.11
3.4
1.6
g/l
1.1
1.2
1.23
216
470
(3002030) Lymphocytes/100 leukocytes in Blood
1216
7480
2.81
96.47
9.4
5.9
%
28.0
28.7
1.41
1163
7010
(3018010) Neutrophils/100 leukocytes in Blood
1205
7381
2.80
96.34
9.2
5.7
%
57.5
56.8
1.10
1157
6940
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
110
113
10.28
96.26
1.6
1.1
ratio
1.2
1.0
2.56
47
48
(3013115) Eosinophils [#/volume] in Blood
1265
7959
2.85
95.70
9.5
6.0
e9/l
0.2
0.2
0.17
1118
7089
(3019198) Lymphocytes [#/volume] in Blood
1259
7927
2.83
94.64
9.1
5.8
e9/l
1.9
2.0
0.98
1106
7081
(3022948) Iron [Moles/volume] in Serum or Plasma
531
2148
3.06
94.37
4.0
2.3
umol/l
13.4
13.7
0.42
514
1980
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
76
50
15.81
87.46
1.3
1.1
%
89.2
91.4
0.12
48
28
(3030467) Casts [#/volume] in Urine by Automated count
759
3864
2.63
85.44
4.4
2.9
e6/l
0.5
0.4
0.20
580
2887
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
75
52
14.99
83.90
1.2
1.1
%
89.7
90.5
0.06
46
30
(3024561) Albumin [Mass/volume] in Serum or Plasma
1002
5880
2.53
82.75
6.6
4.7
g/l
36.0
36.1
0.25
954
5486
(3002582) Erythrocytes [#/volume] in Urine
794
4225
2.54
80.32
4.7
3.0
e6/l
41.0
84.4
1.19
619
3220
(36304419) Bacteria [Presence] in Urine
739
3807
2.56
80.02
4.4
2.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1310
8836
2.64
78.53
12.0
8.6
e9/l
4.0
4.0
0.39
1143
7762
(3018418) pH of Serum or Plasma
760
4004
2.52
78.02
6.1
3.7
ph
7.4
7.4
0.16
143
750
(3021589) Normoblasts [#/volume] in Blood
1095
6849
2.46
76.42
13.9
8.6
e9/l
0.0
0.0
0.55
877
5622
(3037522) Nuclear Ab [Titer] in Serum
511
2246
2.76
75.77
1.7
1.3
titre
617.9
539.8
0.39
134
456
(40758558) Short blood count panel - Blood
727
3831
2.48
73.67
8.5
6.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
888
5134
2.40
72.92
5.6
3.5
e6/l
51.9
91.7
1.25
641
3502
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
529
2419
2.66
72.05
3.5
2.8
mmol/l
2.4
2.4
0.14
476
2112
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
541
2507
2.63
71.66
4.3
3.4
ng/l
286.9
419.0
0.42
391
1695
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
55
29
19.51
70.33
1.3
1.2
%
73.6
64.8
—
20
8
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
77
75
10.67
69.78
1.1
1.1
%
89.4
93.0
0.39
65
60
(3026782) Osmolality of Urine
561
2697
2.55
68.39
3.8
2.7
mosm/kgh2o
537.3
545.6
0.39
484
2300
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
84
95
9.21
68.27
1.6
1.1
u/ml
73.7
9.6
—
15
8
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
69
60
11.91
67.41
1.4
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
209
574
3.98
67.14
1.7
1.5
u/ml
4.8
10.7
—
6
13
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
53
29
18.78
66.62
1.4
1.1
%
91.9
85.6
—
20
8
(3023420) DNA double strand Ab [Units/volume] in Serum
105
162
6.81
65.51
2.4
1.5
iu/ml
38.6
28.1
—
21
9
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
477
2172
2.61
64.64
3.8
2.7
e6/l
2.8
3.0
0.13
245
1155
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
177
446
4.28
63.83
1.5
1.6
titre
97.5
148.0
—
8
15
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
978
6148
2.25
62.89
9.6
5.8
mmol/l
1.2
1.2
0.31
926
5597
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1107
7387
2.24
60.52
7.4
5.9
umol/l
11.8
10.8
1.22
1061
6991
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1045
6825
2.22
60.14
10.1
6.4
mmol/l
1.2
1.2
0.31
907
5788
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1488
11285
2.61
59.83
11.0
7.0
u/l
76.8
76.1
0.22
1435
10619
(3027945) Reticulocytes/100 erythrocytes in Blood
335
1342
2.83
57.88
4.2
2.7
%
1.9
1.8
0.86
299
1204
(3015377) Calcium [Moles/volume] in Serum or Plasma
796
4735
2.19
57.12
3.9
3.2
mmol/l
2.3
2.3
0.20
732
4195
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
663
3670
2.25
56.83
3.3
2.1
mg/l
3.1
2.9
0.85
584
3142
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
475
2327
2.40
53.79
3.6
2.5
e6/l
0.7
1.2
1.76
246
1301
(3000850) Epithelial cells [#/volume] in Urine
555
2932
2.27
52.54
3.7
2.5
e6/l
5.2
6.9
2.42
500
2576
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
372
1649
2.57
52.16
3.5
2.7
umol/l
7.3
7.3
0.00
326
1421
(3013826) Glucose [Moles/volume] in Serum or Plasma
1174
8365
2.10
49.79
7.1
4.5
mmol/l
6.3
6.5
2.62
1117
7718
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
174
518
3.60
49.34
2.9
1.8
g/l
1.3
1.5
1.86
156
456
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
80
126
6.59
48.86
1.3
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
807
5044
2.06
48.73
3.9
3.2
u/l
31.1
30.4
0.27
774
4813
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
80
127
6.54
48.49
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
316
1343
2.63
48.02
3.2
2.4
u/l
29.1
37.7
1.63
275
1133
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
79
126
6.50
47.66
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
79
126
6.50
47.66
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
79
127
6.45
47.30
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
79
127
6.45
47.30
1.3
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
274
1093
2.77
47.14
9.3
7.9
mmol/l
9.1
8.8
0.25
258
1047
(3023368) Bacteria identified in Blood by Culture
606
3448
2.12
46.67
6.5
4.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
149
416
3.81
46.39
1.4
1.2
u/ml
6.6
2.3
0.84
20
42
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1064
7488
1.99
44.51
4.5
2.8
ug/l
109.4
96.9
0.68
1022
7003
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
155
462
3.57
43.77
1.4
1.2
u/ml
76.5
36.8
0.70
12
29
(3052851) Hemolysis interference index of Serum or Plasma
140
391
3.79
43.53
3.8
3.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
146
424
3.65
42.86
1.4
1.2
u/ml
19.3
6.7
0.85
28
70
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
132
359
3.88
42.61
2.7
2.4
g/l
0.2
0.0
0.46
121
333
(3000991) Gas panel - Venous blood
267
1104
2.66
42.59
13.8
8.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
192
665
3.10
42.53
7.6
4.4
mmol/l
24.1
24.1
0.08
175
603
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
127
337
3.97
42.43
2.5
2.5
g/l
0.0
0.0
0.00
116
314
(3044640) Blood type and Crossmatch panel - Blood
743
4681
1.98
42.27
3.3
2.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
127
340
3.94
41.91
2.5
2.4
g/l
0.0
0.0
0.50
116
315
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
163
519
3.35
41.49
3.4
2.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
665
4060
1.99
41.17
2.8
2.1
u/l
183.9
209.9
0.33
645
3852
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
122
323
3.97
40.88
1.3
1.2
u/ml
1.6
4.8
—
7
26
(3031040) Bacteria [#/volume] in Urine by Automated count
1305
10013
2.02
40.80
5.5
4.1
e6/l
299.8
2268.2
1.61
20
122
(3020630) Protein [Mass/volume] in Serum or Plasma
245
996
2.68
40.32
2.8
2.8
g/l
66.1
67.0
1.03
231
917
(3026493) Urate [Moles/volume] in Serum or Plasma
613
3662
2.01
40.19
3.3
2.5
umol/l
2072.7
4902.8
1.67
545
3218
(3037467) Urinalysis macro (dipstick) panel - Urine
1351
10519
2.05
40.18
5.8
4.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
129
360
3.78
40.11
1.4
1.2
u/ml
48.6
39.1
0.28
20
36
(3013707) Erythrocyte sedimentation rate by Westergren method
1412
11193
2.09
39.66
5.9
3.9
mm/h
12.3
10.9
3.46
1353
10425
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
44
43
10.46
39.64
1.7
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
311
1428
2.41
39.59
1.9
1.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
353
1714
2.31
39.54
9.1
5.9
mmol/l
1.0
1.0
0.69
331
1590
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
131
374
3.69
39.40
2.5
2.3
g/l
37.1
38.0
0.91
117
328
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
50
59
8.68
39.21
1.5
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
137
406
3.56
38.96
2.7
2.6
g/l
0.6
1.2
1.25
123
361
(3002385) Erythrocyte distribution width [Ratio]
1598
13341
2.42
38.80
30.3
14.6
%
13.8
13.6
6.03
1584
13070
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
105
264
4.16
37.72
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
105
264
4.16
37.72
1.3
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
448
3.37
37.29
2.7
2.4
g/l
3.2
3.1
0.65
120
350
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
308
1444
2.36
37.25
1.9
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
472
3.30
36.84
2.6
2.4
g/l
7.2
7.3
0.63
122
364
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
472
3.30
36.84
2.6
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
472
3.30
36.84
2.6
2.4
g/l
3.7
3.8
0.35
120
345
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
437
3.38
36.71
2.5
2.5
g/l
10.5
10.4
0.10
124
372
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
558
3322
1.97
36.26
3.3
2.8
ng/l
1251.1
1083.8
0.46
478
2773
(3005719) IgG [Mass/volume] in Serum or Plasma
261
1160
2.45
35.47
3.4
2.7
g/l
10.7
10.5
0.22
248
1065
(3004588) Protein electrophoresis panel - Serum or Plasma
205
815
2.70
35.07
2.4
2.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
115
326
3.69
34.91
1.2
1.2
—
9.1
—
0
6
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
393
2103
2.10
34.08
2.0
1.8
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
36
34
10.78
33.16
1.8
1.1
%
87.7
96.0
0.64
36
34
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
36
34
10.78
33.16
1.8
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
216
913
2.55
32.56
2.2
1.8
g/l
1.4
1.5
0.16
205
845
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
267
1243
2.34
32.56
2.7
2.3
g/l
0.2
0.2
0.12
251
1167
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
250
1133
2.39
32.40
2.8
2.6
ml/min/173m2
79.0
70.8
3.64
170
434
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
218
931
2.52
32.14
3.1
2.9
ng/l
234.1
170.3
0.91
194
844
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
883
6256
1.78
32.03
3.1
2.2
nmol/l
76.5
75.7
0.40
829
5720
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
230
1016
2.44
31.51
5.2
3.8
ng/l
103.1
81.0
1.80
209
901
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
800
5528
1.79
31.43
2.3
1.9
pmol/l
94.8
96.6
0.50
455
2938
(3042936) Bacteria identified in Isolate by Culture
369
1988
2.07
31.15
2.3
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
970
7149
1.75
29.93
4.8
3.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
247
1152
2.32
29.87
12.0
7.2
mmol/l
1.2
1.3
1.66
236
1099
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
148
541
2.89
29.58
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
165
643
2.72
29.22
12.8
10.5
mmol/l
24.0
24.3
0.53
158
603
(3044889) 12 lead EKG panel
1263
10084
1.79
28.96
4.3
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
557
3548
1.81
28.07
3.2
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1735
15543
2.78
27.68
23.5
12.2
mg/l
22.6
21.6
0.62
1502
12090
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1641
14364
2.23
27.29
21.8
10.8
ml/min/173m2
86.2
86.5
0.17
1433
11764
(3007164) IgA [Mass/volume] in Serum or Plasma
528
3338
1.81
27.12
1.8
1.4
g/l
2.3
2.3
0.07
333
2111
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
56
111
5.17
26.93
1.3
1.1
titre
120.0
284.0
—
6
20
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
122
426
2.99
26.45
4.0
2.2
ug/l
229.1
446.7
0.97
115
396
(3023103) Potassium [Moles/volume] in Serum or Plasma
1729
15529
2.66
26.20
25.2
13.4
mmol/l
3.9
3.9
1.64
1714
15089
(3019550) Sodium [Moles/volume] in Serum or Plasma
1725
15479
2.62
26.14
24.8
13.3
mmol/l
139.5
139.6
2.21
1713
15071
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
98
303
3.36
26.04
1.5
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
210
968
2.32
25.96
4.2
2.6
e9/l
78.6
70.7
1.31
121
740
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
169
721
2.48
24.80
1.7
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
104
352
3.07
23.80
3.0
3.7
ratio
9.2
1.8
—
9
29
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
91
286
3.29
23.56
1.4
1.4
u/ml
131.3
108.9
0.34
13
50
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
105
360
3.03
23.50
3.2
3.8
mg/l
30.4
41.6
0.68
90
297
(3034860) Kappa light chains.free [Mass/volume] in Serum
104
360
3.00
22.89
3.2
3.8
mg/l
45.0
77.3
0.84
89
297
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
487
3150
1.74
22.45
1.8
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
237
1218
2.08
22.22
7.3
3.8
mmol/l
1.6
1.9
0.91
196
976
(46235355) HIV 1 and 2 tests - Meaningful Use set
563
3813
1.68
21.82
2.0
1.9
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
22
19
11.71
21.37
1.5
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
696
4998
1.63
21.33
3.8
3.2
ng/l
41.6
42.7
0.03
391
3003
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
199
971
2.18
21.31
1.7
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
251
1338
2.01
21.25
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
348
2070
1.84
21.18
1.7
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
47
99
4.84
21.10
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
258
1397
1.98
20.88
10.4
8.4
mmol/l
0.2
1.1
2.46
212
1087
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
150
655
2.40
20.87
12.2
11.9
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
258
1403
1.97
20.61
10.6
8.3
kpa
12.5
12.7
0.23
248
1339
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
258
1403
1.97
20.61
10.6
8.4
kpa
5.0
5.1
1.36
248
1335
(3021447) Carbon dioxide [Partial pressure] in Venous blood
233
1228
2.03
20.32
7.4
3.8
kpa
5.9
5.8
0.72
221
1190
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
17
10
17.15
20.30
1.4
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
471
3113
1.69
19.68
1.8
1.5
nmol/l
18.7
20.7
2.57
415
2695
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
86
292
3.04
19.59
4.1
3.8
%
58.4
57.4
0.27
86
292
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
250
1377
1.94
19.17
4.5
2.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
21
20
10.61
19.13
1.5
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
74
234
3.25
18.99
1.7
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
298
1744
1.84
18.95
2.4
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
31
50
6.29
18.49
1.2
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
228
1235
1.96
18.33
11.5
9.0
%
95.8
95.8
0.05
222
1190
(3026008) Bacteria identified in Urine by Culture
596
4248
1.59
18.17
3.5
2.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
93
348
2.76
17.77
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1605
14430
1.83
17.49
5.7
4.8
mu/l
1.8
1.9
0.69
1534
13458
(3035350) Ketones [Presence] in Urine by Test strip
944
7521
1.52
17.08
4.2
3.4
estimate
0.0
0.0
0.50
203
1425
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
60
179
3.43
16.91
1.3
1.3
—
—
—
0
0
(44806071)
21
24
8.84
16.79
1.4
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
30
52
5.85
16.67
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
79
281
2.89
16.60
7.3
5.7
iu/ml
343.7
271.1
—
6
37
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1756
16341
2.38
16.59
25.2
13.6
umol/l
77.2
72.9
3.84
1756
16336
(3009261) Glucose [Presence] in Urine by Test strip
950
7611
1.51
16.53
4.2
3.4
estimate
0.0
0.0
1.06
211
1407
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
547
3891
1.58
16.51
1.7
1.6
mmol/l
1.4
1.4
0.37
480
3331
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
61
190
3.29
16.07
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
940
7541
1.50
16.07
6.0
4.6
estimate
0.0
0.0
0.50
220
1451
(3051611) Lipemic interference index of Serum or Plasma
48
128
3.82
15.96
4.7
3.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
62
197
3.22
15.82
2.6
2.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
203
1111
1.93
15.76
4.6
3.9
%
0.7
0.6
0.21
44
238
(40767503) Oxygen content in Capillary blood by calculation
73
256
2.93
15.74
3.0
2.3
%
17.7
16.6
1.44
33
128
(3024891) Influenza virus A+B Ag [Presence] in Specimen
107
456
2.43
15.71
1.2
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
287
1751
1.76
15.70
1.7
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
201
1098
1.93
15.69
4.9
4.2
%
0.1
0.8
0.89
51
247
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
96
390
2.54
15.60
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
50
140
3.64
15.51
1.6
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
799
6240
1.49
15.34
2.2
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1250
10688
1.52
15.31
3.4
3.0
u/l
47.3
41.6
1.56
1191
10118
(3051651) Icteric interference index of Serum or Plasma
37
84
4.47
15.22
4.7
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1620
14737
1.78
15.20
27.7
13.0
%
39.5
39.9
1.60
1355
11402
(3036481) Cortisol [Moles/volume] in Serum or Plasma
251
1487
1.80
15.15
2.4
2.1
nmol/l
335.5
373.6
2.51
240
1374
(3011397) Hemoglobin [Presence] in Urine by Test strip
486
3422
1.57
15.11
3.6
3.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1757
16430
2.30
15.09
15.4
9.4
u/l
27.4
25.6
2.46
1726
15931
(40760888) Immunoglobulin light chains.free panel - Serum
75
274
2.81
15.02
3.1
3.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
27
49
5.58
14.32
1.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
204
1156
1.86
14.20
5.0
4.2
%
0.1
0.1
0.07
56
288
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
81
318
2.62
14.13
1.3
1.3
u/ml
284.8
259.3
0.17
58
192
(3024928) Oxygen saturation in Venous blood
75
284
2.71
14.05
7.9
3.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
96
410
2.41
14.04
1.9
2.2
mg/l
11.8
11.3
0.26
88
382
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
416
2868
1.58
14.04
1.4
1.3
iu/ml
22.9
28.4
0.71
116
893
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1401
12373
1.54
13.89
4.8
4.1
pmol/l
14.5
14.6
0.18
1322
11451
(3024354) Oxygen [Partial pressure] in Venous blood
186
1032
1.89
13.82
6.3
3.2
kpa
4.9
4.7
0.35
173
994
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1503
13511
1.59
13.51
5.8
5.1
mmol/mol
38.6
38.8
0.41
1425
12664
(3017181) Myelocytes/100 leukocytes in Blood
209
1216
1.81
13.34
5.0
4.1
%
0.9
0.9
0.02
59
315
(3012501) Base excess in Blood by calculation
73
281
2.66
13.26
5.9
3.7
mmol/l
2.0
2.3
0.50
47
177
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
28
57
4.97
13.11
1.9
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
28
57
4.97
13.11
1.9
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
82
338
2.49
12.96
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
339
2274
1.60
12.72
2.0
1.7
nmol/l
1012.8
1181.8
3.27
277
1740
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
19
8.49
12.38
1.8
1.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
28
61
4.65
12.13
1.4
1.4
u/l
14.0
14.6
0.14
28
56
(3002256) Pathology report gross observation
288
1878
1.63
12.10
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
185
1071
1.81
11.98
3.2
3.4
pmol/l
4.3
4.6
2.47
165
951
(3048929) Epstein Barr virus Ab [Presence] in Serum
114
566
2.08
11.63
1.4
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
277
2.55
11.55
1.7
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
64
248
2.64
11.51
1.9
1.6
g/l
0.7
0.7
0.16
53
188
(3040151) Glucose [Moles/volume] in Capillary blood
43
134
3.26
11.39
12.4
7.6
mmol/l
6.9
6.9
0.02
37
108
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
518
3890
1.46
11.31
1.4
1.3
u/ml
0.8
1.6
3.07
114
1072
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
126
657
1.98
11.24
2.0
2.1
u/l
38.0
39.4
0.30
110
592
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
586
4513
1.44
11.16
2.9
2.5
u/l
54.5
55.6
0.41
556
4195
(21494815) CD4 cells/100 lymphocytes in Specimen
38
111
3.47
11.14
2.1
2.3
—
37.4
—
0
16
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
50
4.85
10.96
1.8
2.8
—
—
—
0
0
(3010421) pH of Blood
78
341
2.34
10.88
6.7
3.5
ph
7.4
7.4
0.39
72
277
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
78
342
2.34
10.81
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
298
2022
1.56
10.51
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1500
13713
1.49
10.12
30.0
15.4
g/l
331.2
332.6
6.98
1495
13613
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
59
236
2.55
9.99
1.6
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1731
16381
1.84
9.98
19.5
11.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
32
90
3.60
9.94
1.1
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
61
249
2.50
9.91
1.6
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
21
43
4.93
9.79
4.3
4.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50
186
2.73
9.77
1.5
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
81
378
2.20
9.72
2.4
2.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
539
4178
1.41
9.62
4.1
3.2
mmol/l
7.2
7.8
2.25
474
3582
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
375
2724
1.47
9.51
1.3
1.3
u/ml
9.9
11.1
0.12
106
1130
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
178
1094
1.69
9.33
2.2
2.4
au/ml
27.5
22.3
—
5
73
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
41
141
2.95
9.26
1.2
1.2
u/l
39.6
58.4
2.18
30
96
(3010375) cycloSPORINE [Mass/volume] in Blood
25
62
4.07
9.25
24.5
29.5
ug/l
111.0
116.7
0.14
20
52
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
31
90
3.49
9.21
1.1
1.0
—
—
—
0
0
(1002224) Polysomnography panel
127
712
1.84
9.14
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
176
1085
1.69
9.12
4.9
3.3
mmol/l
1.2
1.2
0.63
163
934
(3006184) Hemoglobin [Mass/volume] in Capillary blood
64
279
2.34
9.03
2.6
2.3
g/l
131.4
131.6
0.02
49
208
(1616796) Gas panel - Central venous blood
62
267
2.37
9.00
5.3
3.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1288
11558
1.37
8.79
4.0
3.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
98
3.31
8.77
2.5
2.4
—
—
—
0
0
(3000492) Spirometry study
236
1580
1.57
8.76
1.6
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
48
186
2.62
8.70
1.5
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
56
234
2.44
8.69
1.7
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
65
291
2.28
8.64
2.9
2.4
umol/l
5.3
5.1
0.17
46
215
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
30
89
3.41
8.64
1.2
1.5
u/l
5.2
6.8
0.83
23
72
(3013293) Extractable nuclear Ab [Presence] in Serum
14
22
6.40
8.53
1.6
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
476
3678
1.40
8.49
4.0
3.3
mg/l
492.5
376.0
0.18
326
2351
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
34
111
3.10
8.41
1.1
1.2
u/ml
54.6
61.5
—
5
11
(40760892) CBC W Ordered Manual Differential panel - Blood
474
3666
1.39
8.39
6.4
4.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1630
15302
1.54
8.28
5.3
4.3
mmol/l
2.7
2.8
12.17
1537
14292
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
97
3.23
8.23
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
34
5.04
8.14
1.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
30
93
3.26
8.08
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
203
1339
1.58
8.03
5.4
3.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1609
15086
1.50
7.98
4.8
4.0
mmol/l
4.5
4.7
14.79
1526
14176
(3014765) Yersinia sp identified in Stool by Organism specific culture
90
472
1.95
7.96
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
297
2129
1.47
7.96
2.3
2.4
ug/g
132.9
110.5
0.49
238
1688
(3000093) Morphology [Interpretation] in Blood Narrative
31
101
3.10
7.72
1.2
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
30
96
3.16
7.69
1.6
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
55
242
2.31
7.65
1.3
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
90
479
1.92
7.64
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
89
472
1.93
7.63
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
26
77
3.41
7.53
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
38
141
2.73
7.53
1.4
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
491
3878
1.36
7.52
5.1
4.0
mg/mmol
10.4
9.4
0.21
335
2481
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1598
15003
1.47
7.46
4.7
3.9
mmol/l
1.4
1.5
9.99
1500
14028
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
33
114
2.93
7.45
3.2
3.8
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
22
5.94
7.38
5.2
6.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1546
14435
1.43
7.35
4.3
3.6
mmol/l
1.3
1.3
0.88
1448
13452
(3003327) Ova and parasites identified in Stool by Light microscopy
103
580
1.82
7.35
2.0
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
64
3.63
7.31
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
27
84
3.25
7.26
1.7
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
19
6.35
7.24
1.3
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
11
7
15.80
7.23
1.4
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
19
47
4.07
7.08
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
58
270
2.19
7.08
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
49
213
2.34
7.03
3.3
2.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
33
118
2.83
7.02
1.5
1.4
g/l
33.1
32.5
0.08
26
103
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
91
502
1.85
6.95
1.4
1.6
iu/ml
0.0
0.2
0.69
17
90
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
131
806
1.67
6.87
1.7
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
230
1615
1.48
6.81
1.4
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
68
344
2.01
6.70
1.6
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
101
583
1.77
6.66
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
38
151
2.55
6.62
2.5
2.1
pg
31.4
32.1
0.36
38
151
(36660697) Celiac disease serology panel - Serum
196
1340
1.52
6.60
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
171
1135
1.56
6.59
1.5
1.3
u/ml
133.3
219.5
1.42
164
1048
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
24
74
3.27
6.56
1.9
3.0
u/ml
619.9
945.1
0.92
24
74
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
43
183
2.38
6.49
1.1
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
46
3.94
6.44
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
58
281
2.10
6.43
4.7
2.9
umol/l
34.8
34.0
0.12
49
244
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
18
6.14
6.43
14.7
7.8
mmol/l
6.9
6.7
0.03
11
18
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
33
124
2.69
6.42
1.4
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
42
178
2.39
6.40
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
66
339
1.98
6.26
1.6
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
33
126
2.65
6.24
4.5
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
104
2.82
6.16
1.6
1.3
e6/l
1021.6
2134.7
2.12
22
71
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
89
508
1.79
6.12
1.5
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
82
457
1.83
6.10
3.3
3.3
u/ml
84.4
3101.8
0.78
69
394
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
55
267
2.09
6.08
1.1
1.1
—
—
—
0
0
(4010399)
155
1025
1.56
6.08
1.6
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
114
700
1.67
6.05
1.7
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
35
4.31
6.03
3.1
2.3
—
—
—
0
0
(4027681)
31
117
2.68
6.00
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
16
6.28
5.96
2.2
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
30
112
2.71
5.93
2.3
1.8
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
9
6
15.06
5.90
1.0
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
101
2.80
5.90
2.2
2.4
%
10.3
13.5
1.09
14
55
(3008898) HLA-B27 [Presence]
112
690
1.66
5.88
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
146
962
1.56
5.82
1.8
2.4
ug/l
11.2
6.8
0.95
127
851
(3011648) Oxygen content in Venous blood
29
108
2.71
5.77
2.4
3.5
%
9.6
11.2
0.97
29
108
(3011412) CD3 cells [#/volume] in Blood
33
132
2.53
5.71
2.5
2.7
e9/l
1.0
1.2
0.49
23
83
(3035637) Corticotropin [Mass/volume] in Plasma
42
188
2.26
5.69
1.5
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
92
2.85
5.68
1.7
1.3
e6/l
256742.3
39507.9
0.40
18
53
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
29
109
2.69
5.67
1.1
1.1
u/l
1.0
1.1
0.41
13
53
(3045414) Leukocytes [Presence] in Urine
109
674
1.66
5.65
1.8
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
32
128
2.53
5.54
2.2
2.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
37
159
2.35
5.51
3.4
2.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
152
1024
1.53
5.50
2.8
2.2
u/l
3504.9
5359.7
0.58
71
400
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
21
67
3.16
5.47
1.1
1.1
iu/ml
163.9
188.7
0.20
21
67
(3019832) Treponema pallidum Ab [Presence] in Serum
301
2305
1.37
5.46
1.6
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1795
17459
1.86
5.45
34.6
17.9
e9/l
250.0
258.6
5.81
1775
17070
(3014051) Protein [Presence] in Urine by Test strip
63
335
1.91
5.45
2.1
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
558
4662
1.28
5.44
1.7
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
131
857
1.57
5.41
1.5
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
38
167
2.30
5.39
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
64
345
1.89
5.32
1.2
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
90
2.80
5.31
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
143
959
1.53
5.29
1.2
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
1795
17470
1.84
5.28
34.5
17.9
fl
90.6
90.5
0.17
1790
17261
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
186
1318
1.46
5.26
1.5
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
1795
17472
1.83
5.24
34.5
17.8
pg
30.0
30.2
1.86
1790
17260
(3026361) Erythrocytes [#/volume] in Blood
1795
17473
1.83
5.23
34.6
17.9
e12/l
4.5
4.5
2.50
1771
17054
(3010813) Leukocytes [#/volume] in Blood
1795
17477
1.82
5.17
34.7
18.0
e9/l
6.8
6.7
0.49
1770
17045
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
268
2032
1.37
5.16
1.7
1.8
%
1.4
1.4
0.03
238
1819
(40768806) Pleura Pathology biopsy report
27
105
2.59
4.97
1.8
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
58
310
1.90
4.97
4.2
3.0
mmol/l
24.1
24.8
0.91
52
276
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
117
762
1.57
4.94
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
446
3661
1.29
4.93
1.8
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
155
2.28
4.90
1.5
1.4
g/l
6.7
6.9
0.13
28
109
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
155
2.28
4.90
1.5
1.4
g/l
0.3
0.4
2.62
28
108
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
155
2.28
4.90
1.5
1.4
g/l
2.4
2.9
0.99
28
109
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
45
221
2.06
4.89
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
28
112
2.52
4.88
1.8
2.7
e6/l
701.7
767.7
—
6
43
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1542
14616
1.33
4.87
4.7
4.0
mmol/l
5.8
5.8
0.44
1436
13508
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
80
479
1.70
4.73
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
27
108
2.52
4.72
1.3
1.2
—
—
—
0
0
(4062490)
35
159
2.22
4.63
1.6
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
32
140
2.31
4.62
1.0
1.1
mg/l
208.9
232.6
0.44
27
120
(3017817) Protein [Mass] in Urine collected for unspecified duration
29
122
2.40
4.57
2.7
2.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
57
312
1.85
4.56
1.4
1.8
e6/l
17555.4
13650.2
0.16
36
232
(3044941) Cell count panel - Synovial fluid
42
207
2.05
4.54
1.4
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
90
563
1.63
4.52
1.3
1.4
u/l
11.1
10.3
0.18
70
457
(4035726)
167
1200
1.43
4.41
1.5
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
114
2.39
4.24
1.4
1.5
%
30.1
34.1
0.19
16
70
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
48
255
1.91
4.23
3.7
2.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
37
179
2.09
4.22
1.8
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
63
366
1.75
4.18
1.5
1.5
e6/l
21.7
17.0
0.13
51
286
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
63
366
1.75
4.18
1.5
1.5
e6/l
344.1
1536.0
0.87
54
300
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
106
703
1.54
4.18
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
120
818
1.50
4.16
6.1
3.8
mmol/l
1.3
1.6
0.53
87
609
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
106
704
1.54
4.15
1.5
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
123
847
1.48
4.07
6.0
3.8
ph
7.4
7.4
1.02
26
98
(3022621) pH of Urine by Test strip
136
957
1.45
4.03
2.9
2.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
256
2001
1.32
4.03
2.2
1.9
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
7
10.03
4.01
1.1
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
171
1259
1.39
3.95
3.4
4.1
ug/l
4.8
23.7
1.72
120
1003
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
40
205
1.97
3.93
2.9
2.5
u/ml
5.8
26.2
0.51
35
187
(3000012) Reticulocyte production index
17
59
2.90
3.90
1.9
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
76
2.65
3.90
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
38
192
2.00
3.89
1.2
1.1
g/l
1.5
1.5
0.01
38
174
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
123
856
1.47
3.87
6.1
3.8
kpa
5.1
5.2
0.71
115
804
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
104
701
1.51
3.83
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
104
702
1.51
3.80
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
89
581
1.56
3.79
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
498
4255
1.23
3.78
4.2
3.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
6
5
12.03
3.76
1.2
1.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
6
5
12.03
3.76
1.2
1.0
u/l
160.7
568.2
—
6
5
(3000570) Elastase.pancreatic [Mass/mass] in Stool
66
401
1.67
3.76
1.5
1.4
ug/g
261.5
302.4
0.78
37
219
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
252
1.85
3.73
1.6
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
57
334
1.73
3.70
1.5
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
15
50
3.02
3.69
2.4
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
30
3.68
3.64
1.3
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
16
56
2.87
3.63
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
33
163
2.04
3.61
1.7
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
120
845
1.45
3.57
1.4
1.6
mu/l
275.2
300.8
0.47
106
756
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
68
2.66
3.56
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
14
46
3.06
3.53
3.0
2.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
57
2.82
3.52
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
135
975
1.41
3.51
1.3
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
41
3.19
3.49
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
186
1.95
3.49
1.7
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
11
31
3.56
3.48
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
52
2.90
3.46
2.0
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
32
159
2.03
3.46
2.8
2.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
87
578
1.53
3.45
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
89
595
1.52
3.43
1.5
1.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
58
2.77
3.42
1.2
1.3
%
4.7
5.3
—
6
10
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
174
1318
1.35
3.40
1.3
1.2
iu/ml
195.5
143.7
0.60
62
517
(3017446) Testosterone [Moles/volume] in Serum or Plasma
126
907
1.42
3.35
2.3
2.1
nmol/l
11.1
11.9
0.51
109
800
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
29
141
2.07
3.32
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
68
431
1.60
3.32
2.3
2.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
156
1167
1.37
3.31
1.3
1.4
iu/l
25.1
25.0
0.02
130
997
(3009871) Measles virus Ab [Titer] in Serum
14
48
2.93
3.30
1.6
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
35
183
1.93
3.30
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
34
176
1.95
3.29
1.0
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
23
103
2.25
3.22
1.7
2.8
e6/l
448.6
546.1
0.37
15
94
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
66
2.59
3.21
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
17
66
2.59
3.21
1.6
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
11
6.38
3.18
1.3
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
44
2.97
3.13
1.7
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
8
7.52
3.05
1.2
1.1
u/l
2.2
12.4
—
6
8
(3010937) Rubella virus Ab [Presence] in Serum
8
16
5.02
3.05
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
41
233
1.78
3.01
1.1
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
32
168
1.92
3.00
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
75
499
1.52
2.99
3.8
3.8
g/l
0.2
0.3
0.20
49
205
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
126
1688
0.73
2.99
4.5
4.1
%
32.8
32.1
0.30
97
1195
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
234
1.77
2.97
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
57
2.64
2.96
2.0
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
37
206
1.81
2.91
1.6
1.5
mmol/l
78.0
64.9
0.70
27
177
(40765096) Chromosome analysis panel by Banding
10
30
3.35
2.90
1.0
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
9
6.68
2.87
1.2
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
12
41
2.94
2.86
1.8
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
49
298
1.66
2.85
1.9
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
116
2.08
2.83
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
95
672
1.44
2.82
2.5
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
109
791
1.40
2.81
5.0
5.9
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
11
36
3.07
2.81
1.1
1.8
nmol/l
0.2
0.2
—
5
25
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
284
1.67
2.81
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
30
158
1.91
2.81
1.3
1.6
%
49.8
56.4
0.35
19
106
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
246
1.72
2.81
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
90
2.24
2.80
1.8
1.5
u/l
3.7
8.4
0.92
14
43
(3004809) Band form neutrophils/100 leukocytes in Blood
34
188
1.82
2.75
3.3
3.1
%
0.9
1.3
0.38
29
157
(3000330) Specific gravity of Urine by Test strip
94
668
1.43
2.73
3.1
3.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
50
310
1.63
2.72
4.5
2.3
nmol/l
1.0
0.9
0.30
44
259
(3013637) Mi-2 Ab [Presence] in Serum
11
37
2.98
2.69
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
37
2.98
2.69
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
37
2.98
2.69
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
37
2.98
2.69
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
24
3.76
2.67
1.2
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
12
43
2.80
2.64
1.6
2.4
e6/l
190.0
231.9
—
7
31
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
207
1669
1.27
2.61
1.7
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
119
889
1.36
2.60
1.1
1.1
—
126.2
—
0
17
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
31
170
1.84
2.59
1.4
1.5
mmol/l
13.9
13.1
0.13
13
31
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
6
11
5.47
2.54
1.5
1.9
ug/g
171.8
132.3
—
6
11
(4034850)
28
499
0.55
2.54
7.2
8.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
124
1621
0.75
2.53
5.5
6.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
143
1.90
2.51
1.6
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
16
69
2.33
2.48
1.3
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
39
2.83
2.47
4.9
4.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
151
1.87
2.47
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
204
1.73
2.42
1.3
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
8
6.26
2.37
1.8
4.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
28
3.22
2.30
1.7
1.5
—
—
—
0
0
(3013512) EKG study
432
3800
1.18
2.30
3.8
3.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
10
35
2.87
2.30
1.3
1.2
%
1.1
3.1
—
10
29
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
228
1888
1.24
2.30
2.8
2.9
ug/l
0.7
0.7
0.13
148
1178
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
88
641
1.39
2.27
1.5
1.5
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
6
13
4.63
2.27
1.3
1.3
%
16.3
10.2
—
6
6
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
20
99
2.03
2.26
1.5
2.7
%
45.6
44.5
—
5
33
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
120
1.93
2.26
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
79
2.16
2.25
1.6
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
56
376
1.50
2.22
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
60
2.34
2.22
1.0
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
20
100
2.01
2.21
1.8
2.8
e9/l
0.2
0.2
0.28
15
94
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
100
2.01
2.21
1.1
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
14
4.30
2.15
1.3
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
19
3.69
2.15
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
45
290
1.57
2.15
1.1
1.0
u/ml
0.7
2.1
3.24
11
141
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
57
388
1.48
2.13
1.8
1.7
nmol/l
41.3
40.9
0.05
57
377
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
145
1.80
2.11
1.3
1.2
u/ml
4.1
0.7
0.41
12
56
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
52
348
1.51
2.11
1.7
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
25
3.21
2.09
1.1
1.4
—
—
—
0
0
(44790048)
31
183
1.71
2.08
1.5
1.4
—
—
—
0
0
(44790049)
31
183
1.71
2.08
1.5
1.4
—
—
—
0
0
(44806118)
31
183
1.71
2.08
1.5
1.4
—
—
—
0
0
(44790047)
31
183
1.71
2.08
1.5
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
66
465
1.43
2.08
1.6
2.0
iu/l
2.4
4.9
4.81
22
172
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
10
5.01
2.07
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
40
254
1.59
2.04
1.4
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
44
2.51
2.01
1.5
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
71
511
1.40
2.00
1.1
1.1
u/ml
2.6
4.6
0.49
11
70
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
54
369
1.48
1.99
1.6
1.4
nmol/l
0.7
0.4
0.40
45
297
(3017704) Immunofixation for Urine
15
70
2.15
1.98
1.2
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
119
930
1.30
1.97
2.1
2.7
u/ml
31.7
44.9
0.70
113
900
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
179
1.69
1.95
1.1
1.3
nmol/l
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
11
4.55
1.94
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
33
203
1.64
1.93
2.3
3.1
nmol/l
0.9
0.9
0.09
25
160
(21494755) Public health laboratory ask at order entry panel
155
1897
0.80
1.92
1.3
1.3
—
—
—
0
0
(44813793)
23
128
1.81
1.90
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
136
1.77
1.87
1.1
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
27
159
1.71
1.85
3.0
4.3
u/ml
266.7
103.7
—
10
46
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
17
3.54
1.84
1.3
3.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
17
3.54
1.84
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
40
2.51
1.83
2.0
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
108
1.86
1.82
2.8
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
108
1.86
1.82
1.4
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
23
3.05
1.80
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
24
138
1.75
1.79
2.1
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
73
540
1.37
1.78
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
85
644
1.34
1.78
1.8
1.7
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
18
3.34
1.74
1.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
21
117
1.80
1.74
1.6
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
12
54
2.23
1.74
3.8
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
135
1096
1.25
1.68
3.0
2.6
e9/l
4.6
4.2
0.97
108
902
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
27
165
1.65
1.65
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
221
1.55
1.63
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
47
328
1.44
1.61
2.3
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
6
20
3.01
1.58
1.5
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
57
2.11
1.55
1.5
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
119
963
1.25
1.54
1.1
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
33
2.43
1.53
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
33
2.43
1.53
1.6
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
51
2.16
1.50
2.5
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
226
1.51
1.49
1.8
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
441
4006
1.13
1.49
4.8
3.7
estimate
0.0
0.0
1.49
221
1424
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
29
186
1.57
1.49
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
44
309
1.43
1.48
1.2
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
631
5860
1.12
1.46
4.3
3.5
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
5
16
3.13
1.44
1.2
1.0
u/ml
0.8
0.3
—
5
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
126
1.67
1.40
2.4
2.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
96
1.78
1.39
1.9
1.7
—
—
—
0
0
(4211845)
13
67
1.95
1.38
2.2
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
278
2465
1.15
1.35
1.9
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
354
3194
1.13
1.33
4.2
4.6
ug/l
2.5
2.5
0.05
321
2881
(3002523) Influenza virus A Ag [Presence] in Specimen
45
325
1.39
1.32
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
20
121
1.66
1.31
1.3
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
41
293
1.41
1.29
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
62
1.94
1.27
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
8
35
2.29
1.27
1.0
1.4
mu/l
33.3
69.6
—
8
30
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
138
1.60
1.26
1.9
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
238
2099
1.15
1.26
1.5
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
61
470
1.31
1.21
3.2
1.9
ug/l
1.1
1.9
0.58
54
422
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
54
409
1.33
1.21
1.2
1.1
u/ml
1.1
1.6
0.22
26
171
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
20
124
1.62
1.21
1.5
1.5
g/l
0.9
1.0
0.25
20
124
(3008536) Aspergillus sp Ab [Presence] in Serum
6
26
2.31
1.18
3.0
2.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
44
324
1.37
1.18
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
57
1.94
1.17
2.4
2.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
19
118
1.62
1.15
1.0
1.1
iu/ml
9.8
9.7
—
7
29
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
306
2764
1.13
1.14
2.1
2.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
103
1.66
1.13
1.5
2.2
u/field
2.2
2.5
—
10
54
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
51
1.97
1.11
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
73
1.79
1.11
2.0
1.4
nmol/l
132.2
141.2
0.49
13
73
(3047181) Lactate [Moles/volume] in Blood
53
408
1.31
1.08
4.7
8.2
mmol/l
1.3
1.2
0.30
48
359
(3020874) Milk IgE Ab [Units/volume] in Serum
20
128
1.57
1.08
1.1
1.1
u/ml
18.9
0.9
0.46
12
48
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
32
2.19
1.08
4.6
7.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
554
5909
0.91
1.08
2.7
2.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
23
153
1.51
1.06
1.4
1.7
mosm/kgh2o
292.3
281.2
1.71
15
121
(3047007) Chlamydophila sp Ab [Presence] in Serum
38
280
1.36
1.04
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
78
635
1.24
1.03
7.5
3.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
34
2.06
1.03
4.6
7.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
131
1.53
1.00
1.1
1.2
—
—
—
0
0
(4281824)
24
164
1.47
0.99
1.1
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
23
2.18
0.98
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
84
1.67
0.98
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
69
1.74
0.96
2.7
1.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
23
157
1.47
0.96
1.1
2.3
nmol/l
17.3
20.7
1.03
23
151
(3013139) Helicobacter pylori Ag [Presence] in Stool
121
1039
1.18
0.94
1.3
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
51
1.77
0.94
1.6
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
30
219
1.38
0.89
1.4
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
81
675
1.21
0.89
1.3
1.3
miu/ml
264.4
227.9
0.32
32
339
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
312
0.70
0.88
3.1
2.4
ug/min
27.3
117.7
2.96
12
196
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
56
1.79
0.88
1.3
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
28
203
1.39
0.87
1.6
1.6
mmol/l
7.5
7.6
0.06
15
116
(3019150) Specific gravity of Urine by Refractometry
351
3247
1.10
0.87
3.7
3.7
kg/l
1.0
1.0
0.31
51
447
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
30
2.00
0.87
1.0
1.1
nmol/l
2.3
5.2
—
6
30
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
33
247
1.34
0.85
1.4
1.4
mmol/l
6.4
7.2
1.17
23
170
(3003888) Timothy IgE Ab [Units/volume] in Serum
48
380
1.27
0.84
1.2
1.1
u/ml
5.7
5.3
0.07
32
204
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
88
1.60
0.84
1.5
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
10
57
1.76
0.83
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
46
1.74
0.82
14.9
10.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
165
1.40
0.77
1.1
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
33
252
1.32
0.77
1.4
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
34
1.77
0.76
1.3
1.1
%
19.0
29.7
—
6
29
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
132
1.44
0.76
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
23
166
1.39
0.75
1.1
1.5
—
—
—
0
0
(4198724)
12
75
1.60
0.75
2.8
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
64
765
0.83
0.74
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
167
1.38
0.73
1.1
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
117
1.46
0.71
1.6
2.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
34
264
1.29
0.71
2.4
3.9
u/ml
24.8
27.8
0.10
34
257
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
168
1.37
0.71
1.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
168
1.37
0.71
1.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
168
1.37
0.71
1.1
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
58
483
1.21
0.68
1.5
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
110
1.46
0.68
1.2
1.2
—
—
—
0
0
(4094501)
46
374
1.24
0.68
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
118
0.59
0.68
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
67
568
1.19
0.66
2.1
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
145
1302
1.12
0.66
1.7
1.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
28
1.79
0.66
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
44
1.59
0.65
1.9
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
29
1.73
0.64
2.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
29
1.73
0.64
2.2
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
29
1.73
0.64
2.2
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
71
1.55
0.62
2.0
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
44
361
1.22
0.61
1.2
1.1
u/ml
0.9
1.2
0.25
27
152
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
36
1.67
0.56
1.8
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
36
293
1.23
0.55
1.3
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
65
1.54
0.55
1.2
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
133
1.36
0.55
1.3
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
18
133
1.36
0.55
1.1
1.1
u/ml
0.2
1.2
—
9
40
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
123
0.65
0.54
1.1
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
38
1.58
0.54
2.8
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
99
1.42
0.54
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
20
151
1.33
0.54
3.3
3.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.53
1.2
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
39
1.54
0.53
2.0
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
39
1.54
0.53
2.0
3.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
62
1.45
0.53
1.2
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
32
259
1.24
0.52
1.1
1.1
iu/ml
14.6
1892.4
—
9
68
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
98
0.61
0.52
1.0
2.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
40
1.50
0.51
4.0
2.3
umol/l
15.4
16.6
—
6
40
(40761535) Cells panel - Urine sediment
100
1110
0.90
0.48
3.3
3.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
63
720
0.87
0.48
1.4
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
22
172
1.28
0.48
1.4
1.5
—
—
—
0
0
(3019225) pH of Specimen
120
1317
0.91
0.48
5.0
3.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
42
355
1.19
0.47
1.1
1.1
u/ml
0.2
3.1
—
8
86
(4146454)
8
119
0.67
0.45
4.5
2.7
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
69
1.45
0.44
1.0
2.7
ug/l
1.9
1.1
—
10
63
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
269
2547
1.07
0.42
3.6
4.0
%
24.0
21.2
1.62
97
1132
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
140
1.29
0.42
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
79
1.39
0.40
1.0
1.2
miu/ml
1825.4
1531.2
0.51
11
79
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
1.8
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
304
2898
1.06
0.39
1.8
1.6
pmol/l
435.5
40154084.0
3.28
253
2473
(3048879) Bone marrow aspiration report
5
35
1.43
0.39
2.0
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
355
3400
1.05
0.39
1.5
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
190
0.79
0.35
1.1
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
108
1.30
0.35
1.4
1.3
—
1.5
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
44
1.36
0.34
1.0
1.1
u/ml
28.4
45.2
—
6
44
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
163
1.23
0.34
1.5
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
11
82
1.34
0.34
1.7
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
45
1.33
0.33
1.2
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
46
1.31
0.33
3.0
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
69
626
1.11
0.32
2.3
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
74
1.35
0.32
2.1
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
74
1.35
0.32
2.1
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
74
1.35
0.32
2.1
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
74
1.35
0.32
2.1
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
83
1.33
0.32
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
92
1.31
0.31
5.8
6.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
315
0.86
0.30
1.7
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
54
1.30
0.30
2.3
2.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
54
1.30
0.30
1.6
2.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
55
1.27
0.30
1.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
105
1125
0.93
0.29
1.6
1.7
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
14
112
1.25
0.28
8.9
13.1
nmol/l
786.1
839.9
0.16
14
107
(3011288) Drugs identified in Urine by Screen method
62
565
1.10
0.28
4.2
2.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
8
62
1.29
0.28
2.0
2.3
—
201.4
—
0
12
(1617658) Protocol used for examination of sentinel lymph nodes
16
133
1.20
0.24
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
124
1.21
0.24
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
159
1666
0.95
0.23
1.6
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(4133840)
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
125
1.20
0.22
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
37
410
0.90
0.22
1.4
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
79
1.27
0.22
2.6
1.6
iu/ml
—
1028900.0
—
0
6
(3028707) Methadone [Presence] in Urine by Screen method
40
362
1.11
0.22
3.2
2.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
21.8
—
0
12
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
7.3
—
0
14
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
50
1.20
0.19
1.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
50
1.20
0.19
1.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
51
1.18
0.19
1.0
1.5
ug/l
10.7
8.8
—
6
51
(3020891) Body temperature
53
491
1.08
0.19
5.5
4.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
146
1.17
0.19
1.5
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
62
663
0.93
0.18
1.6
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
58
1.21
0.18
2.0
3.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.17
1.9
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.17
1.9
2.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
61
1.15
0.17
1.1
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
61
1.15
0.17
1.9
2.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
63
1.11
0.17
1.0
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
14
120
1.17
0.16
3.9
3.2
%
54.2
54.3
—
9
89
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
29
266
1.09
0.14
2.4
1.8
pmol/l
202.1
198.3
0.05
29
247
(3023430) Cat dander IgE Ab [Units/volume] in Serum
30
277
1.08
0.12
1.1
1.1
u/ml
0.8
5.4
3.97
16
108
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
497
0.94
0.11
1.9
1.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
24
260
0.92
0.11
1.1
1.1
u/ml
0.1
0.3
—
8
61
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
75
721
1.04
0.10
1.5
1.7
mg/l
2.8
4.2
0.79
49
486
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
56
1.07
0.08
3.8
2.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
29
307
0.94
0.07
1.1
1.1
u/ml
0.6
4.8
2.78
12
112
(3044242) Glucose [Moles/volume] in Arterial blood
7
68
1.03
0.07
2.6
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
76
738
1.03
0.07
2.6
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
81
0.86
0.07
1.6
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
7
82
0.85
0.07
7.6
6.5
—
41.0
—
0
23
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
88
1.02
0.07
1.6
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
129
1.09
0.05
1.9
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
129
1.09
0.05
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
129
1.09
0.05
1.9
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
82
804
1.02
0.04
2.5
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
81
796
1.02
0.03
2.6
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
82
806
1.02
0.03
2.5
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
81
801
1.01
0.01
2.5
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
56
552
1.01
0.01
2.1
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
26
267
0.97
0.01
1.8
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
141
0.99
0.00
2.9
2.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
29
295
0.98
0.00
7.8
3.6
mg/l
17.2
22.9
0.90
24
186
(1761482) Bacteria [#/volume] in Urine by Culture
32
315
1.02
0.00
3.8
3.9
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
52
515
1.01
0.00
4.5
6.8
%
1.8
1.6
0.83
47
485
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
115
1154
1.00
0.00
1.3
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
103
0.97
0.00
1.1
1.2
—
—
—
0
0
(4024509)
12
123
0.98
0.00
1.1
1.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
51
0.98
0.00
1.4
3.2
—
94.2
—
0
11
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
356.6
—
0
5
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
69
1.01
0.00
1.1
1.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
36.7
—
0
9
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
20.3
—
0
9
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
7.4
—
0
9
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_COAGDEFNAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_COAGDEFNAS 1.772 [1.5, 2.09] < 0.001
Birth year 0.998 [0.99, 1.01] 0.663

During the follow-up period (1.1.1998 — 31.12.2019), 528 out of 6334 females with D3_COAGDEFNAS died.

Males

Parameter HR [95% CI] p-value
D3_COAGDEFNAS 1.758 [1.5, 2.06] < 0.001
Birth year 0.989 [0.98, 1.0] 0.025

During the follow-up period (1.1.1998 — 31.12.2019), 579 out of 3194 males with D3_COAGDEFNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_COAGDEFNAS.

N-year risk Females Males
1 0.219% 0.381%
5 1.244% 2.273%
10 2.897% 5.384%
15 5.705% 10.407%
20 9.837% 17.933%

Relationships between endpoints

↥

Index endpoint: D3_COAGDEFNAS – Other and unspecified coagulation defects

GWS hits: 21

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data